+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
TRABI TRABI

Transgene Biotek Share Price

₹2.70 -0.15 (-5.26%)
42.43% Fall from 52W High

19 Aug, 2026 3:29 PM (IST)

Transgene Biotek live price: ₹2.70. It opened at ₹3 vs previous close ₹3; intraday high/low: ₹3/₹3. The 50 & 200 DMA stand at ₹3.00/₹3.20.

Transgene Biotek Performance

  • Today's Low
  • ₹3
  • Today's High
  • ₹3
  • 52 Week Low
  • ₹2
  • 52 Week High
  • ₹5
  • Open Price₹3
  • Previous Close₹3
  • Volume38,540
  • 50 DMA₹3.00
  • 100 DMA₹3.00
  • 200 DMA₹3.20

Transgene Biotek Chart

Investment Returns

  • Over 1 Month -10.89%
  • Over 3 Month -14.01%
  • Over 6 Month + 3.05%
  • Over 1 Year -39.05%

Smart Investing Starts Here Start SIP with Transgene Biotek for Steady Growth!

Invest Now

Transgene Biotek Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -12.7
  • PEG Ratio
  • 0.6
  • Market Cap Cr
  • 21
  • P/B Ratio
  • 2.4
  • Average True Range
  • 0.3
  • EPS
  • -0.2
  • Dividend Yield
  • 0
  • MACD Signal
  • -
  • RSI
  • 40.43
  • MFI
  • 48.79

Latest Stock News Updates

Transgene Biotek Ltd - 526139 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication

Transgene Biotek Ltd - 526139 - 1)The Board Considered And Approved The Unaudited Financial Results (Standalone & Consolidated) Of The Company For The Quarter Ended 30Th June 2026. 2) The Board Considered And Approved The Limited Review Report (Standalone & Consolidated) Of The Company For The Quarter Ended 30Th June 2026.

Unaudited Financial Results for the quarter ended 30th June 2026.

Transgene Biotek Ltd - 526139 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On August 07, 2026.

Sub: Outcome of the Meeting of the Board of Directors held on August 07, 2026. This has reference to our letter dated 22nd July 2026, Intimating the meeting of the Board of Directors of the Company. At a meeting of the Board of Directors of the company held on 07th August 2026 the following decisions have been taken: 1) The Board considered and approved the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter ended 30th June 2026. 2) The Board considered and approved the Limited Review Report (Standalone & Consolidated) of the Company for the quarter ended 30th June 2026. 3) The Board considered and approved the extension of the date of Annual General Meeting (AGM) of the Company for the financial year 2025-26, subject to obtaining the necessary approval from the Registrar of Companies, wherever applicable.

Transgene Biotek Financials

Transgene Biotek Technicals

EMA & SMA

Current Price
₹2.70
-0.15 (-5.26%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹2.90
  • 50 Day
  • ₹3.00
  • 100 Day
  • ₹3.00
  • 200 Day
  • ₹3.20

Resistance and Support

2.77 Pivot Speed
  • R3 3.10
  • R2 3.00
  • R1 2.90
  • S1 2.60
  • S2 2.60
  • S3 2.40

Transgene Biotek Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-07 Quarterly Results & Others
2026-05-29 Audited Results
2026-02-13 Quarterly Results
2025-11-14 Quarterly Results
2025-08-07 Quarterly Results

Transgene Biotek Shareholding Pattern

76.37%
23.64%
0%

About Transgene Biotek

Transgene Biotek is an Indian public biotech firm, established in 1990, focused on R&D for vaccines, oncology, biogenerics, and novel drug delivery (oral/nasal proteins/peptides) for unmet needs, exporting to various global markets and developing treatments for cancer, auto-immune issues, etc View More
  • NSE Symbol
  • TRABI
  • BSE Symbol
  • 526139
  • ISIN
  • INE773D01018

Similar Stocks to Transgene Biotek

Transgene Biotek FAQs

Transgene Biotek share price is ₹2 As on 19 August, 2026 | 22:36

The Market Cap of Transgene Biotek is ₹20.5 Cr As on 19 August, 2026 | 22:36

The P/E ratio of Transgene Biotek is -12.7 As on 19 August, 2026 | 22:36

The PB ratio of Transgene Biotek is 2.4 As on 19 August, 2026 | 22:36

The 52 week High & Low of Transgene Biotek is ₹4.7/₹1.8 respectively As on 19 August, 2026 | 22:36

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23